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The involvement of microtubule dynamics on bioelectric activity of neurons and
neurotransmission represents a fascinating target of research in the context of neural
excitability. It has been reported that alteration of microtubule cytoskeleton can lead to
profound modifications of neural functioning, with a putative impact on hyperexcitability
phenomena. Altogether, in the present study we pointed at exploring the outcomes
of modulating the degree of microtubule polymerization in two electrophysiological
models of epileptiform activity in the rat hippocampus. To this aim, we used in vivo
maximal dentate activation (MDA) and in vitro hippocampal epileptiform bursting activity
(HEBA) paradigms to assess the effects of nocodazole (NOC) and paclitaxel (PAC), that
respectively destabilize and stabilize microtubule structures. In particular, in the MDA
paroxysmal discharge is electrically induced, whereas the HEBA is obtained by altering
extracellular ionic concentrations. Our results provided evidence that NOC 10 µM was
able to reduce the severity of MDA seizures, without inducing neurotoxicity as verified by
the immunohistochemical assay. In some cases, paroxysmal discharge was completely
blocked during the maximal effect of the drug. These data were also in agreement
with the outcomes of in vitro HEBA, since NOC markedly decreased burst activity
that was even silenced occasionally. In contrast, PAC at 10 µM did not exert a clear
action in both paradigms. The present study, targeting cellular mechanisms not much
considered so far, suggests the possibility that microtubule-active drugs could modulate
brain hyperexcitability. This contributes to the hypothesis that cytoskeleton function may
affect synaptic processes, relapsing on bioelectric aspects of epileptic activity.
Keywords: hippocampus, epilepsy, maximal dentate activation, microtubule, electrophysiology, nocodazole,
paclitaxel
INTRODUCTION
Epilepsy is a neurological disorder characterized by recurrent seizure attacks due to synchronous
neuronal firing or increased neuroexcitability of specific brain regions (Hauser and Hesdorffer,
1990; Stafstrom and Carmant, 2015). The broad spectra of epilepsy-related neurobiological
targets include, overall, synaptic components, neurotransmitter mechanisms or metabolic
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pathways (Bialer et al., 1996, 2001; Scharfman, 2007; Roseti et al.,
2013; Moccia et al., 2015), but only few studies have investigated
the potential role of the cytoskeleton. In this regard, hippocampal
epilepsy is often associated with sprouting of principal cell axons
in both humans and animal models (Bausch, 2005). On this
point, microtubule cytoskeletal alterations underlying aberrant
axonal sprouting have been implicated in the development of
posttraumatic epilepsy (Larner, 1995; McKinney et al., 1997;
Chuckowree and Vickers, 2003; Wilson et al., 2012). The
neuronal microtubule cytoskeleton underpins many cellular
processes including protein transport, cell division, neurotrophic
support but it also plays a fundamental role in regulating
voltage-gated ion channels activity and the affinity of several
neurotransmitters for their receptors (Whatley and Harris,
1996). Noteworthy, disruptive mutations in α- or β-tubulin
may lead to neurological diseases in both the central and
peripheral nervous system and dysfunctions of the microtubule
cytoskeleton likely determine aberrant neurotransmission
(Craddock et al., 2010; Gardiner and Marc, 2010; Millecamps
and Julien, 2013). Furthermore, microtubules have been found
to be extremely important for the general bioelectric activity of
neurons serving as biological electrical wires that can transmit
and amplify electric signals via the flow of condensed ion clouds
(Craddock et al., 2010). Therefore, even if the role of microtubule
dynamics on neuroexcitability and synaptic communication has
been already suggested (Whatley and Harris, 1996; Gardiner
and Marc, 2010), it is still to be elucidated whether this may
be directly related to hyperexcitability and hence, importantly
contribute to epileptic phenomena. In order to achieve a
deeper insight on the impact of microtubules on neuronal
hyperexcitability in mammalian brain, we studied the effect
of the pharmacological manipulation of the microtubule
polymerization on two different electrophysiological acute
models of hippocampal epilepsy in the rat. To this purpose,
we administered nocodazole (NOC) and paclitaxel (PAC),
previously chosen to study hippocampal processes for their
reported action on cytoskeleton (Craddock et al., 2010; Fanara
et al., 2010), but also recognized in the clinical practice as anti-
mitotics in different forms of cancer (Jordan and Wilson, 2004).
In detail, NOC is mainly known for its affinity to the major
microtubule structural protein tubulin, reducing microtubule
instability and promoting depolymerization. Conversely,
PAC binds to tubulin at a different site and hyperstabilizes
polymerizedmicrotubules (Gotaskie and Andreassi, 1994; Dinter
and Berger, 1998; Marx et al., 2007). We exploited two drug-free
models of epileptiform activity, the in vivo electrically-induced
maximal dentate activation (MDA; Stringer and Lothman,
1992; Carletti et al., 2015), and the hippocampal epileptiform
bursting activity (HEBA), characterized by in vitro neuronal
burst firing evoked by changes in the electrolytic concentrations
of cerebrospinal fluid (Sokolova et al., 1998; Sardo et al.,
2012). Noticeably, the MDA study was primarily conducted
with experimenters blind to the drugs identity to prevent the
possibility of bias from interpretation of electrophysiological
outcomes. Then, in vitro assessment followed for a deeper
understanding of what observed in vivo. Coupling in vivo
and in vitro methods allowed us to evaluate the effects of
perturbing the microtubule assembly process on the genesis
and maintenance of epileptic activity, in the hippocampus, in
both intact neuronal network and isolated brain slices. On the
whole, this study can be placed in the research field of synaptic
mechanisms underlying pathophysiological alterations of
neural transmission, conceivably relapsing on hyperexcitability
phenomena.
MATERIALS AND METHODS
In Vivo MDA Model
Animals
Male Wistar rats, weighing 240–280 g, were anesthetized with
urethane (1.2–1.4 g/kg intraperitoneally, i.p.; Maggi and Meli,
1986; Hara and Harris, 2002). The animals were positioned
in a stereotaxic apparatus for skull exposition (David Kopf
Instruments, Tujunga, CA, USA). The body temperature was
maintained at 37–38◦C using a heating pad; hearth rate and pupil
diameter were monitored during all the experimental session.
A craniotomy was performed to expose a wide area of the
right cerebral cortex; then, the dura was reflected. A stimulating
depth electrode (coaxial bipolar stainless steel electrode: external
diameter 0.5 mm; exposed tip 25–50 µm) was placed in the
angular bundle (AB) on the right side according to the stereotaxic
coordinates of the Atlas of Paxinos andWatson (1998; AB: 1 mm
anterior to the interaural line; 3–5 mm dorsal to it and 4.4 mm
lateral to the midline). A glass recording electrode, filled with
1% fast Green in 2 M NaCl, was stereotaxically placed in the
dentate gyrus (DG) on the right side (DG: 6 mm anterior to the
interaural line; 1.8 mm lateral to the midline and 3.0 mm ventral
to the cortical surface). The site for intracerebroventricular
(ICV) injection was localized into the right cerebral ventricle
(RV; 0.8 mm posterior to the bregma; 1.4 mm lateral to the
midline and 3.3 mm from the dura). The animal was grounded
through a subcutaneous Ag/AgCl wire in the scapular region. The
bioelectric activity of the structure examined was amplified and
recorded through a low level DC pre-amplifier (Grass 7B, West
Warwick, RI, USA), then processed using the SciWorks package,
version 5.0 (Datawave Technologies, Longmont, CO, USA).
All procedures were performed in strict accordance with the
European directive 2010/63/EU and the institutional guidelines,
authorized by the Italian Ministry of Health (authorization n◦
258-95-A) and approved by the Committee for the Protection
and Use of Animals of the University of Palermo. All efforts were
made to minimize animal suffering and to reduce the number of
animals used.
Maximal Dentate Gyrus Activation and Ictal Events
Identification
The technique originally used by Stringer and Lothman (1992)
to trigger the activation of the DG was modified as described in
our previous research (Sardo et al., 2006, 2008, 2009). In detail,
10 s duration trains of 20 Hz stimuli were given through the
AB stimulating electrode. Individual stimuli consisted of 0.3 ms
biphasic pulses. The stimulus intensity was initially below that
necessary to elicit response and then, increased in 100 µA steps
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until MDA occurred (threshold intensity). A stimulus train was
administered every 2 min until MDA appearance and then every
10 min for up to 3 h. A stimulus intensity 100µA higher than the
threshold intensity for the stimulations was used. In every case,
the stimulation intensity varied from 200 µA to 400 µA. MDA
was defined by a shift of the extracellular potential in DC-coupled
recordings as well as by the presence of bursts of population
spikes of 20–40 mV in DC-coupled trace. First, we took into
consideration the % of responses to AB stimulation to evaluate
the possible drug-induced suppression of paroxysmal events.
Furthermore, the following parameters were analyzed to assess
changes of epileptic activity: (i) the time of onset (or latency) of
the MDA was considered as the time from the beginning of AB
stimulation to the midpoint of the shift of the DC potential; (ii)
the total duration of the MDA was measured from the midpoint
of the shift of the DC potential to the point at which the evoked
paroxysmal activity abruptly ceased; (iii) the afterdischarge (AD)
duration was measured from the end of AB stimulation to the
end of the epileptiform activity (Figure 1A). The time of onset
represents an indicator of the susceptibility of the DG to respond
to stimulation; MDA and AD quantify the extent of epileptic
discharge.
The correct positioning of electrodes was verified through
iontophoretic Fast Green injection (50 µA for 10 min) and a
small electrolytic lesion (20 mA for 10 s), as previously described
(Sardo et al., 2008).
Drug Treatment
NOC, PAC and all reagents were purchased from Sigma
Chemical Co., (Sigma, St. Louis, MO, USA), if not differently
specified. The study was performed by blind experimenters on
four groups of rats (n = 6 each): in the 1st (controls) the
animals were studied for a period of about 3 h in order to
verify possible modifications of MDA parameters due to the
FIGURE 1 | (A) Representative maximal dentate activation (MDA) trace. Measurements of time of onset (latency), duration of maximal dentate gyrus (DG) activation
(MDA) and after discharge (AD) during and after a stimulus train (400 µA, 20 Hz) delivered for 10 s to the angular bundle (AB). (B) Time course of MDA parameters in
vehicle-treated controls. Each value represents the mean duration of D% of baseline ± SEM.
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repetitive stimulations. In the 2nd group the animals received
administration of vehicle (1 µL of 15% dimethyl sulfoxide
solution, DMSO, ICV). In the 3rd and the 4th group, 1 µL
of either NOC or PAC were injected ICV in order to reach a
10 µM final concentration in the cerebrospinal fluid for both
drugs. For all the injections, a 2.5 µL Hamilton microsyringe
(Supelco, Bellefonte, PA, USA) connected to a microinjection
pump (2Biological Instruments, Besozzo, VA, Italy) was used. All
injections were delivered at a rate of 0.5 µL/min and the needle
was left in place for one additional minute following the infusion
to allow the diffusion of the drug away from needle tip. ICV
injections were carried out after five stimulations that produced a
stable MDA (baseline period) and the following observation last
up to 120 min. The dosages of administration were used on the
basis of previous studies on these drugs and pilot experiments
(Furukawa and Mattson, 1995; Puthanveettil et al., 2008; Miller
et al., 2015).
Statistical Analysis
The chi-square (χ2) test was used to compare the % of responses
to AB electrical stimulation following each drug treatment within
the same experimental group and also between treated groups
and vehicle-treated controls.
For each studied parameter (the time of onset, MDA or
AD durations), data from each animal were expressed as %
difference (D%) vs. the baseline value measured in the last
MDA response preceding vehicle (in the 2nd group) or drug
(in 3rd and 4th groups) injection (Figure 1B). Then, in each
group D% data were averaged (mean ± SD) on the basis of
time elapsed from the first stimulation following the treatment
and then plotted as mean D% ± SEM (see Figure legends).
For significant changes, maximum mean D% and the related
mean absolute values are reported. The time course of response
parameters was analyzed using a two-way analysis of variance
(ANOVA), since the occurrence of drug-induced suppression of
paroxysmal response did not allow the use of a repeatedmeasures
ANOVA. This analysis was followed by Bonferroni post hoc test.
A between-treatments comparison was made to assess the effects
of the treatments in the 3rd, and 4th groups respectively vs.
vehicle-treated controls. Differences were considered statistically
significant when P was less than 0.05.
Immunohistochemistry
At the end of the MDA protocol (namely 2 h after NOC
ICV injection), for histological verification of NOC ICV effects,
six animals received an overdose of pentobarbital i.p. and
were then whole-body perfused with normal saline followed
by 10% buffered formalin. The brains were removed, postfixed
in the same fixative overnight and then cryoprotected in 30%
sucrose/PBS. Subsequently, the brains were sliced in serial
sections, used for the following immunohistochemical assay
according to established procedures (Morterá and Herculano-
Houzel, 2012; Woeffler-Maucler et al., 2014; Kadakkuzha et al.,
2015). Four representative 40 µm floating horizontal sections
containing DG, RV and entorhinal cortex (EC; from 3.0 to
5.1 mm, ventral to cortical surface) were rinsed at least three
times in PBS, pretreated with 0.5% Triton X-100-PBS for 20 min
at room temperature to rupture membrane, and then immersed
in 10% normal goat serum (NGS) in PBS for 60 min followed
by incubation with primary antibodies containing 3% NGS, and
0.1% Triton X-100 in PBS for 24 h on a rotating shaker at 4◦C.
After primary incubation, sections were washed four times with
0.1% Triton X-100 in PBS and then incubated in secondary
antibodies containing 3%NGS in PBS for 1 h on a rotating shaker
at room temperature. Primary antibodies consisted of rabbit
anti-NeuN (1:200, ABN78; Millipore), and mouse anti-β-tubulin
(1:500, T4026; Sigma-Aldrich). Brain sections from control and
treated animals were analyzed per region (n = 3 brains per
group). Secondary antibodies consisted of anti-rabbit Alexa Fluor
488 (1:1500; Invitrogen) and anti-mouse Alexa Fluor 546 (1:1500;
Invitrogen). For counterstaining of nuclei, the sections were
stained using Hoechst Stain solution.
Confocal Microscopy and Data Analysis
Labeled sections were mounted on slides sequentially according
to the rat brain atlas with a fluoro-gel with DAPI (Fluoro-Gel
with DAPI; Electron Microscopy Sciences), cover slipped, and
imaged using a Zeiss LSM 780 confocal microscope system. For
each section, a 10× tile scan image was obtained and followed
by image captures with 63× objective of random positions in
the regions of interest from both hemispheres. Representative
images were chosen from the same positions in vehicle and
NOC-treated rats. Only projection images were shown. The
NeuN positive neurons as well as DAPI positive neurons were
counted using Image J software. The ratio of NeuN positive
neuron number/DAPI number in each image (mean ± SEM)
was calculated and analyzed by a t-test to outline the presence
of histological modifications in treated vs. control brains. Four to
six 63× images from each region were used for the analysis.
In Vitro HEBA Model
Hippocampal Epileptiform Bursting Activity in Rat
Brain Slices
Brain slices were obtained from 4- to 6-week-old male Wistar
rats. In detail, rats were deeply anesthetized with halothane,
then decapitated; brains were carefully removed and glued to
the stage of a vibroslicer (Vibroslice–Campden, mod. MA752).
Slicing was carried out in ice-cold (3–4◦C) oxygenated artificial
cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl,
3 KCl, 1.25 NaH2PO4, 1.8 MgSO4, 1.6 CaCl2, 26 NaHCO3,
and 10 Glucose, pH 7.4. aCSF was constantly bubbled with a
95% O2, 5% CO2 gas mixture. From the resulting horizontal
slices (350–400 µm thickness), only the hippocampi were
immediately transferred to a holding chamber containing normal
oxygenated aCSF and held at 33◦C. After 1 h recovery, a
slice was rapidly transferred to a standard Interface Recording
Chamber, continuously perfused (2 ml/min) with normal
aCSF at 35 ± 0.5◦C; a warmed, humidified 95% O2–5%
CO2 vapor was maintained over the exposed surface of
the slice. In order to induce hippocampal bursting activity,
the slice was then perfused with aCSF, containing modified
concentrations of Ca2+ (1.0 mM), Mg2+ (1.5 mM) and K+
(8.0 mM; Sokolova et al., 1998). Electrophysiological recordings
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from the CA1 hippocampal subregion were performed by
means of borosilicate glass microelectrodes (5–7 MΩ), filled
with 2 M NaCl, and lowered to a depth of 100–150 µm
below the cut surface of the slice, at which ionic changes
accompanying the epileptiform acivity are maximal (Sokolova
et al., 1998). Electrical activity was recorded using a Multiclamp
700B amplifier (Axon Instruments, Molecular Devices, CA,
USA, 300 Hz–3 kHz band pass). The raw activity signal
was video monitored through a Tektronix 5113 oscilloscope
(Beaverton, OR, USA). The resulting Transistor–Transistor
Logic pulses were used to trigger a digitizing oscilloscope
(Gould 500 DSO) for displaying selected full waveforms
of discriminated impulses. The raw electrical activity was
also digitally converted; in addition to fully storing it on
a computer for off-line analysis, raw activity was passed
through a software window discriminator and digital signals
were on-line displayed. Furthermore, a ratemeter histogram
of burst activity was continuously displayed and updated
each 5 s on the computer screen together with a counter
window, to detect on-line variations of paroxysmal bursting
rate. All computer operations were performed using the pClamp
package, version 10.5.0 (Molecular Devices, Berthoud, CO,
USA).
Drug Treatments
After a steady epileptiform bursting discharge (control period)
was obtained and maintained for at least 10 min, the slices were
perfused for 10min withmodified aCSF containing NOC 10µM.
At the end of drug administration, slices were again perfused
with drug-free modified aCSF for 10 min (wash-out period).
The duration and dosages of administration were chosen taking
into consideration previous studies on these drugs, the reported
equilibration time course of other antiepileptic drugs and pilot
experiments in hippocampal slices at the depth of recording
(Furukawa and Mattson, 1995; Petrini et al., 2004; Puthanveettil
et al., 2008; Sardo et al., 2012).
Statistical Analysis
In order to detect statistically significant drug-related changes,
we analyzed extracellular bursting activity of drug treatment
periods, then compared vs. control values and wash-out periods,
respectively. As control activity we took into account 5 min
recorded immediately before switching to drug-included aCSF
and as wash-out period, the last 5 min recorded after switching
back to drug-free aCSF (Figure 2A). In detail, we analyzed burst
activity, taking into consideration three parameters (Figure 2B):
(1) burst frequency; (2) number of events in burst; and (3) burst
duration. Then, we examined whether any treatment-related
changes in busting activity were coupled with intraburst single
spike waveform (ISW) alterations. Since single spikes waveforms
are characterized by a positive phase (hereafter named ‘‘peak’’)
and a negative phase (hereafter named ‘‘antipeak’’), we took in
consideration four fundamental parameters of ISW (Figure 2C):
(1) peak amplitude; (2) duration of the positive phase (hereafter
‘‘time to peak’’); (3) antipeak amplitude; and (4) duration of
the negative phase (hereafter ‘‘time to antipeak’’). The burst
analysis was performed separately for both control and wash-
out periods. For each recording it consisted of measuring
the three parameters for each burst and then calculating the
average for all the parameters. Afterwards, for all the burst
parameters, the average values from each recording were also
averaged for control and wash-out periods, respectively, for
subsequent statistical analysis. Furthermore, ISW parameters
were calculated from those bursts analyzed in the control and
wash-out periods. ISW parameter values were averaged for each
recording and as performed for burst analysis, combined into
average absolute values from control and wash-out periods for
statistical comparisons. The same procedure was adopted for
burst and ISW analyses in the treatment period, considered as
the last 5 min after switching to drug-included aCSF. All these
parameters were considered as mean ± SEM and analyzed by a
one-way ANOVA, comparing values from each treated period to
the related control and wash-out periods. For all statistical tests
used, the null hypothesis was rejected at a probability level (P)
lower than 0.05.
RESULTS
In Vivo MDA Model
Effect of Treatments on the Number of MDA
Responses
A comprehensive bar graph showing the effects of each treatment
on MDA responses is reported in Figure 3A.
In untreated and vehicle-injected controls repetitive AB
stimulations always induced a MDA response along the
experimental observation period, therefore in Figure 3A only the
bar for vehicle-treated controls is reported.
NOC ICV injection reduced the % of responses to AB
stimulation. In particular, NOC-treated group displayed a
decrease in the percentage of responses to AB stimulation
starting from 20th to 80th min, reaching a maximal effect at the
50th and 70th min when animals exhibited 50% of responses
(χ2 = 8.57, DF = 1, P = 0.0034).
Conversely, AB stimulations always induced a MDA response
in animals treated with PAC.
Effect of Treatments on MDA Parameters
In untreated and vehicle-injected controlsMDA parameters were
not altered during the experimental session (Figure 1B).
In the group receivingNOC ICV injection, a within-treatment
analysis revealed that the drug induced a significant increase in
the time of onset (F(12,60) = 2.29; P = 0.0209). Bonferroni post-
test showed statistical significance from 40th to 60th min, with
a maximum mean effect of +74.01 ± 40.19% at 60th min (from
4.26 ± 0.95 s to 7.10 ± 1.28 s; P = 0.005). Moreover, a reduction
of MDA duration emerged (F(12,60) = 7.068; P < 0.0001) vs.
baseline, in particular from 30th to 100th min, with a maximum
effect of −72.79 ± 15.11% at 60th min (from 23.24 ± 6.83 s
to 5.41 ± 2.65 s; P < 0.0001). Similarly, the treatment induced
a reduction in the AD duration (F(12,60) = 5.469; P < 0.0001),
namely from 30th to 100th min, with a maximum effect
of −79.98 ± 13.34% at 60th min (from 17.57 ± 6.99 s
to 2.67 ± 1.40 s; P < 0.0001). As for between-treatments
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FIGURE 2 | (A) Representative hippocampal epileptiform bursting activity (HEBA) trace. The yellow boxes indicate the periods (5 min each) of control, treatment
(NOC for nocodazole) and wash-out, taken into consideration for analysis. The bar on the top represents the continuous perfusion with modified aCSF, containing
drug-free aCSF (green) or drug-included aCSF (red). Chromatic fading along the bar indicates the progressive filling of the recording chamber with the different aCSF
solutions. (B) Measurements of burst parameters, i.e., burst duration and the number (N◦) of events in burst. (C) Measurements of intraburst single spike waveform
(ISW) parameters: peak amplitude indicated as (1), time to peak indicated as (2), time to antipeak indicated as (3) and antipeak amplitude indicated as (4).
comparisons of NOC vs. vehicle-treated group, a two-way
ANOVA for the time of onset revealed significant main effects
of stimulus time (F(12,113) = 2.13, P = 0.0201) and treatment
(F(1,113) = 1.943, P < 0.0001), but not their interaction
(F(12,113) = 0.91, P = 0.53). The same analysis performed
on MDA showed significant main effects of stimulus time
(F(12,113) = 6.291, P < 0.0001), treatment (F(1,113) = 65.13,
P < 0.0001) and their interaction (F(12,113) = 4.277; P < 0.0001).
Similarly, in the AD durations a significant main effect
emerged for stimulus time (F(12,113) = 4.508, P < 0.0001),
treatment (F(1,113) = 33.55, P < 0.0001) and their interaction
(F(12,113) = 3.208, P = 0.0006).
In contrast, a within-treatment analysis on PAC
effect revealed no significant effects for any of the MDA
parameters. A two-way ANOVA did not show a significant
between-treatments main effect for stimulus time, treatment or
their interaction for PAC-injected animals, when compared to
vehicle group (Figure 3B).
Immunohistochemical Analysis after Nocodazole ICV
Injection
In the light of NOC effects, to evaluate the eventual
neuronal loss due to excessive NOC-induced microtubule
depolymerization, we conducted immunohistochemical staining
of β-tubulin on coronal sections including DG, RV and EC.
Figures 4, 5 report confocal projection images of cellular
staining in control and NOC-treated brains. Both NeuN
(green) co-stained with β-tubulin protein (red), along with
the nuclear stain Hoechst (blue) and the merged images are
presented. As shown in Figure 6, no significant changes
in the NeuN/DAPI positive neurons ratio emerged from
statistical analysis of treated vs. control animals in the RV
(NOC: 48.14% ± 2.23; Control: 45.71% ± 2.32), DG (NOC:
47.77% ± 2.50; Control: 47.92% ± 1.32), and EC (NOC:
51.20% ± 1.84; Control: 52.92% ± 0.99), indicating that the
NOC ICV injection has no neurotoxic effect in the detected
brain regions.
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FIGURE 3 | (A) The bar graph shows the percentage of responses to the AB stimulation recorded in the experimental groups, as indicated in the legend:
vehicle-treated controls (CTR), nocodazole (NOC) and paclitaxel (PAC) during the progressive stimuli. (B) Effects of NOC (10 µM) and of PAC (10 µM) on the time
course of MDA parameters during the progressive stimuli as in the legend. Each value represents the mean of D% ± SEM of each treatment per stimulus vs. baseline
values. Within-treatment statistically significant D% is indicated for ∗P < 0.05 vs. baseline values.
In Vitro HEBA Model
Induction of HEBA in Rat Brain Slices
Hippocampal slices (n = 24) presented a stable, spontaneous
single spike activity with normal aCSF (Figure 7A). The
perfusion with the modified aCSF induced continuous burst
activity in all slices (Figure 7B). Recordings were conducted on
eight slices per treatment from hippocampal CA1 subregion.
Each burst was characterized by clusters of extracellular
potentials (1–4 mV amplitude). For all parameters taken into
account, no statistically significant differences were observed
between control values of burst activity in both NOC and PAC-
treated slices.
Effect of Nocodazole at 10 µM and Paclitaxel at
10 µM on HEBA
As for analyses on the effect of NOC on burst activity, a one-
way ANOVA on burst frequency showed statistical significance
(F(2,23) = 6.60; P = 0.006), with a significant decrease during
NOC 10 µM (from 0.73 ± 0.21 Hz to 0.09 ± 0.03 Hz;
P < 0.001) vs. control. Furthermore, the number of events in
bursts was significantly changed (F(2,23) = 3.51; P = 0.048),
particularly NOC reduced this parameter from 2.58 ± 0.19 to
2.019± 0.01 (P < 0.05) vs. control period. Lastly, burst duration
was reduced following NOC treatment, though not-significantly
(Figures 7C, 8). Noteworthy, after treatment with NOC in some
recordings epileptiform activity was completely suppressed,
though recovering during wash-out period. Figures 2A, 7 show
a representative effect of NOC displayed both in compressed and
extended time-scale traces.
Statistical analysis revealed that the parameters related
to burst activity after PAC treatment were not significantly
changed, though it seems that PAC slightly increases burst
frequency and duration with respect to control period
(Figures 7D, 8).
Given that NOC resulted effective in modifying burst
parameters, analyses on the ISW were performed on the
related recordings. Statistical differences were found between
control, NOC and wash-out period for the for the antipeak
amplitude (F(2,23) = 7.19; P = 0.0042) and for the time to
antipeak (F(2,23) = 4.67; P = 0.02). In detail, post hoc analysis
showed that the antipeak amplitude significantly decreased
during the administration of NOC 10 µM (from 0.7 ± 0.1 mV
to 0.39 ± 0.021 mV; P < 0.01) and during the wash-out
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FIGURE 4 | The confocal projection images of coronal brain section showing immunohistochemical staining in vehicle-treated controls (CTR) and
NOC-treated rats. The hippocampal subregions analyzed are DG and entorhinal cortex (EC). Both NeuN (green) co-stained with β-tubulin protein (red), along with
the nuclear stain Hoechst (blue) and the merged images are presented. Scale bar corresponds to 200 µm for 1st and 2nd row (10×), to 20 µm for the others (63×).
(from 0.7 ± 0.1 mV to 0.40 ± 0.005 mV; P < 0.05)
respectively vs. control period. Furthermore, during NOC
treatment the time to antipeak was significantly increased vs.
control (from 1.49 ± 0.19 ms to 0.62 ± 0.026 ms; P < 0.05;
Figure 9).
DISCUSSION
Dynamic changes in microtubule packaging system could
represent the cutting edge of novel studies on the synaptic
bases of epilepsy. Synaptic efficiency is strongly influenced by
the microtubule cytoskeleton, exerting not only a mechanical
action on cell morphology and plasticity, but also an operative
role on transport, signaling and amplification of ion cloud
(Brady et al., 2003; Craddock et al., 2010). For instance,
cytoskeleton provides support to the trafficking of neurotrophic
factors (Gardiner et al., 2011) and could be part of a system
of conduction for the flux of charged ions along the axons
(Craddock et al., 2010). The well-known ‘‘dynamic instability’’
of microtubules modulates synaptic activity and also neuronal
response to insults (Poulain and Sobel, 2010). Consequently, a
role played by microtubules in pathophysiological alterations
of synaptic transmission, with a relapse on hyperexcitability
phenomena, has been proposed (Furukawa and Mattson,
1995; Chuckowree and Vickers, 2003). To shed new light
on this still elusive field, in the present research we tested
drugs differently modulating microtubule polymerization, i.e.,
NOC and PAC, in two in vivo and in vitro models of
drug-free epileptiform activity, the MDA and HEBA. This
represents the main novelty of the current paper: the usage
of drugs, widely administered as anti-mitotics (Jordan and
Wilson, 2004; Gascoigne and Taylor, 2009; Endo et al.,
2010), here applied to study epileptic states occurring in the
hippocampus, a brain region where bioelectric activity can
be modulated by agents of varied nature (Rizzo et al., 2009,
2014; Roseti et al., 2013; Allegra et al., 2015; Carletti et al.,
2015).
NOC ICV injection protected animals in the MDA model
from electrically-evoked paroxysmal discharge. In detail, this
treatment decreased response to AB stimulation, starting from
20th min after drug administration. This suggests that NOC
may intervene on activation threshold of epileptic discharge;
moreover, it could mitigate the paroxysmal firing of DG
neurons, based on the activity of glutamatergic reverberatory
circuit of the hippocampal-parahippocampal system. In this
perspective, NOC administration managed to modify MDA
parameters, describing epileptiform severity. Indeed, in animals
still responding to the stimulation, a marked reduction of the
duration of both MDA and AD and a corresponding increase
in the time of onset were observed. These data from MDA
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FIGURE 5 | The confocal projection images of coronal brain section
showing immunohistochemical staining in vehicle-treated controls
(CTR) and NOC-treated rats in the right cerebral ventricle (RV). Both
NeuN (green) co-stained with β-tubulin protein (red), along with the nuclear
stain Hoechst (blue) and the merged images are presented. Scale bar
corresponds to 200 µm for 1st and 2nd row (10×), to 20 µm for the others
(63×).
parameters hint that, once altered discharge is elicited in the
DG, NOC ICV can attenuate its typical features. Whereas, the
ICV administration of PAC did not influenceMDA response nor
discharge parameters. Then, immunofluorescence staining was
performed in order to exclude that NOC efficacy in protecting
from paroxysmal discharge was due to alterations that could
harm cell integrity, eventually leading to a reduction in the
FIGURE 6 | Bar graph shows the ratio of NeuN positive neuron
number/DAPI number in NOC-treated vs. controls (CTR) for each
subregion: RV, DG and EC. Values are expressed as percentage
ratio ± SEM.
FIGURE 7 | Representative traces of hippocampal activity when slices
are perfused with normal aCSF (A), modified aCSF (B), NOC (C) and
PAC (D).
number of neurons. Histochemical assay verified that NOC
did not induce neuronal loss in the brain regions mainly
involved in the MDA-related phenomena. This result seems
to be consistent with the reported action of NOC as rather
reversible and rapid with a relatively low toxicity (De Brabander
et al., 1976; Lu et al., 2012). Nonetheless, a deeper histological
analysis in future studies could further detail on putative
morphological changes to neuronal population occurring after
drug injection.
In order to support these findings with an in vitro approach,
NOC and PAC were tested in the HEBA model. NOC was
able to inhibit epileptiform burst activity, by diminishing burst
frequency and the number of events in burst. Then, a further
analysis on ISW data was carried out to better characterize drug-
induced effects. We observed that alterations of hippocampal
bursting activity were accompanied by a marked decrease
in the amplitude and an increase in the duration of the
negative phase. This is consistent with previous observations
that lower spike amplitudes may result in a reduced probability
to initiate bursts and also in a minor number of events
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FIGURE 8 | Bar graphs showing NOC and PAC effects on burst parameters. Each value represents mean ± SEM of, respectively, control (CTR), treated and
wash-out periods, as indicated in the legend. Statistical significance is indicated for ∗∗P < 0.001 and for ∗P < 0.05 vs. control period. (A,D) Effects of NOC and PAC
on burst frequency respectively. (B,E) Effects of NOC and PAC on the number (N◦) of events in burst respectively. (C,F) Effects of NOC and PAC on burst duration
respectively.
within bursts (Harris et al., 2001). Accordingly, the increased
duration of the negative phase could be responsible for the
prolonged activity suppression. This is likely due to a longer
hyperpolarization of neuron potentials, eventually reducing
spike triggering. Importantly, burst activity seems to recover,
though not always reaching control values, when NOC treatment
is washed out. This also supports the verified absence of
NOC neurotoxicity to the brain regions involved. In contrast,
PAC did not seem to affect in vitro epileptiform activity.
All considered, these data support the in vivo findings since
NOC attenuates both genesis and severity of epileptiform
activity.
The current results provide innovative evidence of
the possible impact of microtubule cytoskeleton on
hyperexcitability-based diseases. Noticeably, our experimental
design exploiting two drug-free models of epileptiform activity
(Stringer and Lothman, 1992; Sardo et al., 2012) allowed us
to evaluate the results in an intact neuronal network, but
also to exclude the influence of blood-brain barrier (BBB;
Jefferys and Haas, 1982) and to appreciate whether any effect
directly influenced hippocampal neurons. In this context,
some molecular studies previously reported that, in kainate
(KA)-induced epileptic state, altered microtubule formation
contributed to aberrant neurogenesis in the DG with an
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FIGURE 9 | Effects of NOC on ISW parameters. Each value represents mean values ± SEM Statistical significances vs. control period (CTR) are indicated for
∗∗P < 0.001 and ∗P < 0.05. Bar graphs show the effect of treatments on the peak amplitude (A), time to peak (B), antipeak amplitude (C) and time to antipeak (D).
increase in the gene expression of tubulin and microtubule-
associated proteins (Represa et al., 1993; Pollard et al., 1994;
Hendriksen et al., 2001; Sato and Abe, 2001). In contrast,
drugs such as NAP, davunetide, that preserve microtubule
functioning, protect against KA toxicity (Zemlyak et al., 2007,
2009). Therefore, manipulating the degree of microtubule
polymerization could represent an intriguing strategy to act
on hyperexcitability phenomena, though a comprehensive
approach has not been adopted yet. The present research falls
within this remit, by exploring the effects of microtubule-
active agents in hippocampal epilepsy, and evidencing a
clear antiepileptic effect only for NOC. In this regard, it
has been reported that NOC and PAC differently regulate
microtubule dynamics. On the one hand, NOC, depolymerizing
microtubules, stimulates a morphological re-arrangement
of neuritis (Chuckowree and Vickers, 2003). On the other
hand, PAC is known to facilitate the polymerization of
tubulin monomers, ultimately forming stable, non-functional
microtubules (Gotaskie and Andreassi, 1994); this mechanism
determined abnormalities of microtubule aggregation and
growth within neurites in various animal models, producing
PAC-induced aberrant structures (Letourneau and Ressler,
1984; Black, 1987; George et al., 1988; Theiss and Meller, 2000;
Chuckowree and Vickers, 2003). These distinct outcomes
could reflect different affinity of these drugs to the neuronal
isoforms of αβ tubulin heterodimers, each responsible for
specific processes such as cell viability, neurite outgrowth and
protection against oxidative stress (Xu et al., 2002; Guo et al.,
2010).
In addition, these alterations of microtubule dynamics may
impact on other fundamental aspects of neuronal transmission
including axonal transport. Actually, it was demonstrated that
microtubule-based transport underpins the long-range transport
into distal axons and dendrites (Puthanveettil et al., 2008).
Disruption of intracellular transport is known to lead to axonal
pathologies (Saxena and Caroni, 2007; Perlson et al., 2010;
Millecamps and Julien, 2013). In this light, compounds affecting
axonal transport machinery could modulate the neuronal
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hyperexcitability in mammalian brain, as also reported in
previous studies on dimethyl sulfoxide, a strong microtubule
stabilizer and fast axonal transport blocker (Donoso et al.,
1977; Carletti et al., 2013). Moreover, it can be hypothesized
that NOC may act on increased excitability occurring during
paroxysmal events, by dissipating the excessive propagation
of action potentials resulting from microtubule cytoskeleton
ability to directly influence electrical currents and altered
neurotransmission (Craddock et al., 2010). Intriguingly, this
could be also likely explained by NOC modulation of fast
mitochondrial transport which could reduce the amount of
mitochondria in the synaptic terminals and ultimately impair
substantial neurotransmission processes such as exocytosis,
endocytosis and vesicle recycling (Morris and Hollenbeck, 1995;
Miller et al., 2015).
In conclusion, our study show for the first time a clear effect
of NOC in modulating acute electrophysiological paroxysmal
activity, though further multidisciplinary data are surely required
in order to better characterize a complete effectiveness profile.
In this view, this microtubule-active agent would also deserve
investigations to elucidate its implication in the hallmarks
(e.g., axonal sprouting) of hippocampal neurogenesis occurring
in chronic epilepsy (Chuckowree and Vickers, 2003; Wilson
et al., 2012). Taken all this into consideration, focusing
on new factors not strictly related to bioelectric features
of synaptic transmission, microtubule cytoskeleton turns up
amongst the possible mechanisms involved in hyperexcitability-
based diseases.
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